| News

Adobe develops new technology in Basel

12.08.2019

The US-based company Adobe is developing a technology in Basel that will make it possible to display content on screens more quickly. Basel is a central R&D location for the American software provider, says Christoph Kull, head of Central Europe at Adobe.

Computer chip (Img: stephen4/Pixabay)

Basel plays an important role for Adobe. “Basel is a central location for our research and development and is Europe’s largest training center for Adobe Experience Manager,” Christoph Kull, Vice President and Managing Director Central Europe at Adobe, is quoted in an article in the Sunday newspaper NZZ am Sonntag. “So many of today’s customer experiences also include architecture and innovation developed in Basel”.

The US software company is accelerating the development of its Adobe Experience Manager (AEM) from its offices in Basel, a program that allows users to centrally manage their data volumes and adapt them to their end devices. The global support center for critical AEM application cases also happens to be located in Basel, according to Florian Schaulin, manager of the Basel offices. The company is also currently working on a technology that will make it possible to display individual content on screens more quickly.

Adobe has been present in Basel since 2010, when it acquired Day Software, which was founded in 1993. Adobe’s employees come from prominent institutions including the Federal Institute of Technology in Zurich and the University of Basel. Adobe also supports the university financially and awards doctoral theses. In addition, Adobe offers four apprenticeships in Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.